48,474
edits
(→Multiple polyps with PPI use: tweak) |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 92: | Line 92: | ||
COMMENT: | COMMENT: | ||
Several fundic gland polyps were removed previously. Fundic gland | Several fundic gland polyps were removed previously. Fundic gland | ||
polyps are associated with familial adenomatous polyposis (FAP) | polyps are associated with familial adenomatous polyposis (FAP), | ||
gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS), | |||
and proton pump inhibitor (PPI) use. | and proton pump inhibitor (PPI) use. | ||
PPI use appears to be the most likely explanation in this case, | PPI use appears to be the most likely explanation in this case, | ||
in the context of the provided history; however, FAP should be | in the context of the provided history; however, FAP and GAPPS should be | ||
considered clinically. | considered clinically. | ||
</pre> | </pre> | ||
Line 105: | Line 106: | ||
- Fundic gland polyposis, see comment. | - Fundic gland polyposis, see comment. | ||
- NEGATIVE for intestinal metaplasia. | - NEGATIVE for intestinal metaplasia. | ||
- NEGATIVE for | - NEGATIVE for Helicobacter-like organisms. | ||
- NEGATIVE for dysplasia and negative for malignancy. | - NEGATIVE for dysplasia and negative for malignancy. | ||
Line 112: | Line 113: | ||
were seen at the time of grossing. | were seen at the time of grossing. | ||
Fundic gland polyps are reported in association with proton pump inhibitor use | Fundic gland polyps are reported in association with proton pump inhibitor use, familial | ||
adenomatous polyposis (FAP), and gastric adenocarcinoma and proximal polyposis of the | |||
stomach (GAPPS). The possibility of FAP and GAPPS should be considered. | |||
</pre> | </pre> | ||
Line 129: | Line 130: | ||
were seen at the time of grossing. | were seen at the time of grossing. | ||
Fundic gland polyps are reported in association with proton pump inhibitor use | Fundic gland polyps are reported in association with proton pump inhibitor use, familial | ||
adenomatous polyposis (FAP), and gastric adenocarcinoma and proximal polyposis of the | |||
stomach (GAPPS). The possibility of FAP and GAPPS should be considered. | |||
</pre> | </pre> | ||
edits